Table 1.

Sex, age and vaccine administered to participants by study groups

Caracteristic		Beep Group		Non- beep Group		P value
	E	E (n)	P (%)	E (n)	P (%)
Sex	Male	118	50.0	126	53.6	0.43
	Female	118	50.0	109	46.4	0.43
Age group(in weeks)	< 1	40	16.9	43	18.3	0.70
	[2-6]	55	23.3	45	19.1	0.20
	[7-10]	45	19.1	42	17.9	0.64
	[11-14]	37	15.7	51	21.1	0.09
	[15-52]	45	19.1	48	20.4	0.71
	> 52	14	5.9	06	2.6	0.06
Vaccine	BCG	40	16.9	46	19.6	0.60
	OPV	177	75	180	76.9	0.62
	PENTA	137	58.1	135	57.4	0.89
	Pneumo	136	57.6	135	57.4	0.96
	MV	45	19.1	48	20.4	0.71
	YFV	45	19.1	48	20.4	0.71

BCG: Bacille de Calmette et Guérin - E: Effectif - P: percentage - OPV: 386 Oral Poliomyelitis Vaccine- PENTA: Diphteria, pertusis, Tetanus, Hepatitis B, Haemophilus- YFV: Yellow fever vaccine - MV: Measles Vaccine